BETHANY FISHER: Open Payments
NPI 1477743961 · ATASCADERO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 50 payments from 12 companies in 2025. Trend: 2023 $1,550 · 2024 $1,509 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $255 |
| Novo Nordisk Inc | 12 | $155 |
| GlaxoSmithKline, LLC. | 8 | $141 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Amgen Inc. | 5 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| PFIZER INC. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: REZDIFFRA, VRAYLAR, QULIPTA, OTEZLA, Wegovy, UBRELVY, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across CA — which companies pay providers there.
